share_log

3: Initial statement of beneficial ownership of securities-Director Neuman John

3: Initial statement of beneficial ownership of securities-Director Neuman John

3：首次持股声明-董事 Neuman John
美股SEC公告 ·  06/14 16:28
Moomoo AI 已提取核心信息
SeaStar Medical Holding Corp's director and 10% owner, John Neuman, has filed an initial statement of beneficial ownership with the SEC, as per Form 3 requirements. The document, dated June 5, 2024, indicates that Neuman does not beneficially own any non-derivative or derivative securities of the company. The filing, which is a routine disclosure for individuals in Neuman's position, was completed on June 14, 2024. This formality is part of the regulatory compliance under Section 16(a) of the Securities Exchange Act of 1934, which mandates reporting by directors, officers, and principal shareholders of public companies.
SeaStar Medical Holding Corp's director and 10% owner, John Neuman, has filed an initial statement of beneficial ownership with the SEC, as per Form 3 requirements. The document, dated June 5, 2024, indicates that Neuman does not beneficially own any non-derivative or derivative securities of the company. The filing, which is a routine disclosure for individuals in Neuman's position, was completed on June 14, 2024. This formality is part of the regulatory compliance under Section 16(a) of the Securities Exchange Act of 1934, which mandates reporting by directors, officers, and principal shareholders of public companies.
SeaStar医疗控股公司的董事兼10%股东John Neuman根据Form 3规定向SEC提交了初始的有益所有权申报书。该文件日期为2024年6月5日，表明Neuman并不拥有该公司的任何非衍生或衍生证券的有益所有权。该申报书于2024年6月14日完成。这种形式上的程序是《1934年证券交易法》16(a)条规定的监管合规的一部分，该条规定了公共公司的董事、高管和主要股东的报告要求。
SeaStar医疗控股公司的董事兼10%股东John Neuman根据Form 3规定向SEC提交了初始的有益所有权申报书。该文件日期为2024年6月5日，表明Neuman并不拥有该公司的任何非衍生或衍生证券的有益所有权。该申报书于2024年6月14日完成。这种形式上的程序是《1934年证券交易法》16(a)条规定的监管合规的一部分，该条规定了公共公司的董事、高管和主要股东的报告要求。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息